RayBonnerWorthyMDPhD
Psychiatry • New Orleans, LAPrincipal Investigator New Orleans Site MAPS sponsored Phase 3 clinical research trial investigating efficacy of MDMA-assisted psychotherapy for PTSD
Dr. Worthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Private Practice
320 N Carrollton Ave Suite 202
New Orleans, LA 70119Phone+1 504-336-3003Fax+1 504-556-2859
Education & Training
Medical University of South CarolinaResidency, Psychiatry, 2008 - 2012
Tulane University School of MedicineClass of 2008
Certifications & Licensure
LA State Medical License 2012 - 2024
SC State Medical License 2009 - 2012- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 383 citationsMDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyJennifer M. Mitchell, Michael P. Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman
Nature Medicine. 2021-05-10 - 6 citationsInpatient detoxification from a synthetic cannabinoid and control of postdetoxification cravings with naltrexone.Christopher Rodgman, Christopher D. Verrico, Ray B. Worthy, Erica E. Lewis
The Primary Care Companion for CNS Disorders. 2014-08-14 - 14 citationsMDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman
Focus. 2023-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
